Post job

ExecuPharm's revenue is $76.0 million.

What is ExecuPharm's revenue?

ExecuPharm's annual revenue is $76.0M. Zippia's data science team found the following key financial metrics about ExecuPharm after extensive research and analysis.
  • ExecuPharm has 750 employees, and the revenue per employee ratio is $101,333.
  • ExecuPharm peak revenue was $76.0M in 2024.

On this page

Peak revenue
$76.0M (2025)
Company peak revenue
Revenue / employee
$101,333
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$76.0M (2025)
Company peak revenue
Revenue / employee
$101,333
Company revenue / employee

ExecuPharm competitors

ExecuPharm's top competitor, Merck, earned an annual revenue of $64.2B.

ExecuPharm's smallest competitor is TKL Research with revenue of $380.0K last year.

ExecuPharm revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of ExecuPharm, including salaries, political affiliations, employee data, and more, in order to inform job seekers about ExecuPharm. The employee data is based on information from people who have self-reported their past or current employments at ExecuPharm. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by ExecuPharm. The data presented on this page does not represent the view of ExecuPharm and its employees or that of Zippia.

ExecuPharm may also be known as or be related to ExecuPharm, ExecuPharm Inc, ExecuPharm Inc., Execupharm and Execupharm, Inc.